Related Experiment Video
Updated: Jul 20, 2026
Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique
Published on: March 14, 2016
NIR-II AIEgens for Infectious Diseases Phototheranostics
Dingyuan Yan1, Zheng Li1, Michelle M S Lee2
1Center for AIE Research, Guangdong Provincial Key Laboratory of New Energy Materials Service Safety, College of Materials Science and Engineering, Shenzhen University, Shenzhen, 518060, China.
Second near-infrared (NIR-II) aggregation-induced emission luminogens (AIEgens) offer a powerful phototheranostic approach for combating infectious diseases. These advanced materials show great promise in pathogen detection and treatment, addressing critical public health threats.
Area of Science:
- Biomedical Engineering
- Materials Science
- Nanotechnology
Background:
- Pathogenic infectious diseases remain a significant global health concern.
- Phototheranostics offers a promising strategy for disease control due to its broad-spectrum activity, controllability, and resistance to pathogen adaptation.
- Second near-infrared (NIR-II) aggregation-induced emission luminogens (AIEgens) are emerging as highly effective phototheranostic agents.
Purpose of the Study:
- To systematically review recent advancements in NIR-II AIEgens for combating bacterial and viral pathogens.
- To highlight the importance of molecular design and nanoplatform formulation for enhanced theranostic performance.
- To discuss current challenges and future research directions in this field.
Main Methods:
- Review of literature on NIR-II AIEgens for phototheranostic applications.
- Analysis of molecular design strategies for optimizing AIEgen properties.
- Evaluation of nanoplatform formulations for improved delivery and efficacy.
- Classification of studies based on disease models (bacterial and viral infections).
Main Results:
- NIR-II AIEgens demonstrate deep tissue penetration, excellent biocompatibility, and tunable photophysical properties.
- Aggregation-enhanced emission and theranostic performance are key advantages for pathogen targeting.
- Successful application in various disease models highlights their potential for treating bacterial and viral infections.
- Tailored molecular design and nanoplatforms are crucial for achieving high therapeutic efficiency.
Conclusions:
- NIR-II AIEgens represent a cutting-edge phototheranostic platform for infectious disease management.
- Further research into molecular design and nanomedicine is essential for clinical translation.
- This technology holds significant potential for combating future epidemics and improving public health outcomes.
